{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Hereditary haemorrhagic telangiectasia",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_warfarin",
          "name": "Warfarin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_clopidogrel",
          "name": "Clopidogrel"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_ibuprofen",
          "name": "Ibuprofen"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_rivaroxaban",
          "name": "Rivaroxaban"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_apixaban",
          "name": "Apixaban"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_enoxaparin",
          "name": "Enoxaparin"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_dabigatran",
          "name": "Dabigatran"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_heparin",
          "name": "Heparin"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_fondaparinux",
          "name": "Fondaparinux"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_nsaids",
          "name": "NSAIDs"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_phenprocoumon",
          "name": "Phenprocoumon"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.36,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.2,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.15,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 1.8,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Aspirin acts on COX, which is involved in hemostasis."
          ],
          "safety_risk": [
            "高出血风险可以抵消预期益处。"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "Aspirin's overall safety in bleeding disorders needs further investigation."
        ]
      },
      {
        "hypothesis_id": "H2",
        "score": 0.32,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.2,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.3,
          "safety_risk": 0.15,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 1.6,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Warfarin inhibits coagulation factors critical for hemostasis."
          ],
          "safety_risk": [
            "长期使用风险和出血事件的关系需进一步厘清。"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "Warfarin's effect in patients with bleeding disorders needs additional evidence."
        ]
      },
      {
        "hypothesis_id": "H3",
        "score": 0.31,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.2,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.3,
          "safety_risk": 0.15,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 1.5,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Clopidogrel targets COX, affecting platelet activation."
          ],
          "safety_risk": [
            "Potential for increased bleeding must be considered."
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "Clopidogrel's hemocompatibility in vascular complications is unclear."
        ]
      },
      {
        "hypothesis_id": "H4",
        "score": 0.29,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.2,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.3,
          "safety_risk": 0.15,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 1.4,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Ibuprofen inhibits COX and affects hemostasis."
          ],
          "safety_risk": [
            "出血风险需要更加明确的评价。"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "The long-term effects of ibuprofen in bleeding disorders remain uncertain."
        ]
      },
      {
        "hypothesis_id": "H5",
        "score": 0.3,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.2,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.3,
          "safety_risk": 0.15,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 1.5,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Rivaroxaban inhibits specific coagulation factors."
          ],
          "safety_risk": [
            "出血风险需纳入评估，尤其是在那些易出血的患者中。"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "Rivaroxaban's safety in patients with bleeding disorders is not fully established."
        ]
      },
      {
        "hypothesis_id": "H6",
        "score": 0.29,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.2,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.3,
          "safety_risk": 0.15,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 1.4,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Apixaban inhibits coagulation factors similarly to rivaroxaban."
          ],
          "safety_risk": [
            "安全性考虑在出血性疾病中同样重要。"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "Apixaban's effect on bleeding risks is currently unclear."
        ]
      },
      {
        "hypothesis_id": "H7",
        "score": 0.28,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.2,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.3,
          "safety_risk": 0.15,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 1.3,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Enoxaparin is effective in inhibiting factors in coagulation."
          ],
          "safety_risk": [
            "高出血风险需详细评估。"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "Enoxaparin's safety in hereditary hemorrhagic conditions isn't fully established."
        ]
      },
      {
        "hypothesis_id": "H8",
        "score": 0.27,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.2,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.3,
          "safety_risk": 0.15,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 1.3,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Dabigatran inhibits thrombin, impacting coagulation."
          ],
          "safety_risk": [
            "对出血风险的考量需在患者中加以重视。"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "Dabigatran's profile in hereditary bleeding disorders is still unclear."
        ]
      },
      {
        "hypothesis_id": "H9",
        "score": 0.26,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.2,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.3,
          "safety_risk": 0.15,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 1.3,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Heparin prevents thrombus formation via factor inhibition."
          ],
          "safety_risk": [
            "在出血性疾病中使用需多加小心。"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "Heparin's broad application in hereditary conditions is still under investigation."
        ]
      },
      {
        "hypothesis_id": "H10",
        "score": 0.25,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.2,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.3,
          "safety_risk": 0.15,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 1.3,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Fondaparinux inhibits specific anticoagulation factors."
          ],
          "safety_risk": [
            "使用时考虑对出血风险的潜在影响。"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "Fondaparinux's implications in hereditary bleeding remain to be established."
        ]
      },
      {
        "hypothesis_id": "H11",
        "score": 0.24,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.2,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.3,
          "safety_risk": 0.15,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 1.3,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "NSAIDs can affect overall hemostasis."
          ],
          "safety_risk": [
            "潜在的出血风险需要特别考虑。"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "NSAIDs' safety in bleeding disorders requires additional evidence."
        ]
      },
      {
        "hypothesis_id": "H12",
        "score": 0.23,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.2,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.3,
          "safety_risk": 0.15,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 1.3,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Phenprocoumon affects coagulation mechanisms."
          ],
          "safety_risk": [
            "其在出血性疾病中的安全性需纳入考量。"
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "Phenprocoumon's effects on bleeding risks are not well understood."
        ]
      }
    ],
    "ranking": [
      "H1",
      "H2",
      "H3",
      "H5",
      "H4",
      "H6",
      "H7",
      "H8",
      "H9",
      "H10",
      "H11",
      "H12"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "target_cox",
          "type": "Target",
          "label": "Cyclooxygenase (COX)",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_factors",
          "type": "Target",
          "label": "Coagulation Factors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_hemostasis",
          "type": "Pathway",
          "label": "Hemostasis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_anticoagulation",
          "type": "Pathway",
          "label": "Anticoagulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_vascular",
          "type": "Phenotype",
          "label": "Vascular Complications",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_bleeding",
          "type": "Phenotype",
          "label": "Bleeding Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_aspirin",
          "type": "Target",
          "label": "OffTargetAspirin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_aspirin",
          "type": "Pathway",
          "label": "RiskPathwayAspirin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_aspirin",
          "type": "Phenotype",
          "label": "AdversePhenotypeAspirin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_warfarin",
          "type": "Target",
          "label": "OffTargetWarfarin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_warfarin",
          "type": "Pathway",
          "label": "RiskPathwayWarfarin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_warfarin",
          "type": "Phenotype",
          "label": "AdversePhenotypeWarfarin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_clopidogrel",
          "type": "Target",
          "label": "OffTargetClopidogrel",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_clopidogrel",
          "type": "Pathway",
          "label": "RiskPathwayClopidogrel",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_clopidogrel",
          "type": "Phenotype",
          "label": "AdversePhenotypeClopidogrel",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ibuprofen",
          "type": "Target",
          "label": "OffTargetIbuprofen",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ibuprofen",
          "type": "Pathway",
          "label": "RiskPathwayIbuprofen",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ibuprofen",
          "type": "Phenotype",
          "label": "AdversePhenotypeIbuprofen",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_rivaroxaban",
          "type": "Target",
          "label": "OffTargetRivaroxaban",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_rivaroxaban",
          "type": "Pathway",
          "label": "RiskPathwayRivaroxaban",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_rivaroxaban",
          "type": "Phenotype",
          "label": "AdversePhenotypeRivaroxaban",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_aspirin",
          "target": "target_cox",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Aspirin inhibits COX enzymes, which are involved in hemostasis."
        },
        {
          "source": "drug_warfarin",
          "target": "target_factors",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Warfarin modulates coagulation factors, affecting bleeding risk."
        },
        {
          "source": "drug_clopidogrel",
          "target": "target_cox",
          "relation": "acts_on",
          "weight": 0.78,
          "agent": "Proponent",
          "rationale": "Clopidogrel inhibits platelet activation by targeting COX."
        },
        {
          "source": "drug_ibuprofen",
          "target": "target_cox",
          "relation": "acts_on",
          "weight": 0.76,
          "agent": "Proponent",
          "rationale": "Ibuprofen inhibits COX, impacting hemostatic balance."
        },
        {
          "source": "drug_rivaroxaban",
          "target": "target_factors",
          "relation": "inhibits",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Rivaroxaban inhibits specific coagulation factors."
        },
        {
          "source": "drug_apixaban",
          "target": "target_factors",
          "relation": "inhibits",
          "weight": 0.73,
          "agent": "Proponent",
          "rationale": "Apixaban directly inhibits coagulation factors."
        },
        {
          "source": "drug_enoxaparin",
          "target": "target_factors",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Enoxaparin inhibits factors in the coagulation cascade."
        },
        {
          "source": "drug_dabigatran",
          "target": "target_factors",
          "relation": "inhibits",
          "weight": 0.68,
          "agent": "Proponent",
          "rationale": "Dabigatran inhibits thrombin, a key factor in coagulation."
        },
        {
          "source": "drug_heparin",
          "target": "target_factors",
          "relation": "inhibits",
          "weight": 0.66,
          "agent": "Proponent",
          "rationale": "Heparin prevents thrombus formation through factor inhibition."
        },
        {
          "source": "drug_fondaparinux",
          "target": "target_factors",
          "relation": "inhibits",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Fondaparinux inhibits anticoagulation factors."
        },
        {
          "source": "drug_nsaids",
          "target": "target_cox",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "NSAIDs often inhibit COX, posing bleeding risks."
        },
        {
          "source": "target_cox",
          "target": "pathway_hemostasis",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "COX activity is essential for normal hemostasis."
        },
        {
          "source": "target_factors",
          "target": "pathway_anticoagulation",
          "relation": "involved_in",
          "weight": 0.78,
          "agent": "Proponent",
          "rationale": "Coagulation factors are critical in the anticoagulation pathway."
        },
        {
          "source": "pathway_hemostasis",
          "target": "phenotype_bleeding",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Disruption in hemostasis leads to bleeding disorders."
        },
        {
          "source": "pathway_anticoagulation",
          "target": "phenotype_bleeding",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Altered anticoagulation can increase bleeding risks."
        },
        {
          "source": "drug_aspirin",
          "target": "n_ot_aspirin",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能对出血风险的影响"
        },
        {
          "source": "n_ot_aspirin",
          "target": "n_rp_aspirin",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与出血机制相关"
        },
        {
          "source": "n_rp_aspirin",
          "target": "n_adv_aspirin",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "导致出血性并发症"
        },
        {
          "source": "n_adv_aspirin",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险成立则抵消预期获益"
        },
        {
          "source": "drug_warfarin",
          "target": "n_ot_warfarin",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "出血风险增加"
        },
        {
          "source": "n_ot_warfarin",
          "target": "n_rp_warfarin",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "直接与出血机制有关"
        },
        {
          "source": "n_rp_warfarin",
          "target": "n_adv_warfarin",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "导致重度出血事件"
        },
        {
          "source": "n_adv_warfarin",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险成立则抵消预期获益"
        },
        {
          "source": "drug_clopidogrel",
          "target": "n_ot_clopidogrel",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响出血机制"
        },
        {
          "source": "n_ot_clopidogrel",
          "target": "n_rp_clopidogrel",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与出血通路相关"
        },
        {
          "source": "n_rp_clopidogrel",
          "target": "n_adv_clopidogrel",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可引发出血性症状"
        },
        {
          "source": "n_adv_clopidogrel",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "风险成立则抵消预期获益"
        },
        {
          "source": "drug_ibuprofen",
          "target": "n_ot_ibuprofen",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "影响抗凝机制"
        },
        {
          "source": "n_ot_ibuprofen",
          "target": "n_rp_ibuprofen",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "关联出血风险途径"
        },
        {
          "source": "n_rp_ibuprofen",
          "target": "n_adv_ibuprofen",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "导致出血性恶化"
        },
        {
          "source": "n_adv_ibuprofen",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险成立则抵消预期获益"
        },
        {
          "source": "drug_rivaroxaban",
          "target": "n_ot_rivaroxaban",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "对出血风险增高"
        },
        {
          "source": "n_ot_rivaroxaban",
          "target": "n_rp_rivaroxaban",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与出血机制相关"
        },
        {
          "source": "n_rp_rivaroxaban",
          "target": "n_adv_rivaroxaban",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "导致相关出血"
        },
        {
          "source": "n_adv_rivaroxaban",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "风险成立则抵消预期获益"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "score": 0.36,
        "graph_snapshot_ref": "GE_H1_round5",
        "key_assumptions": [
          "Aspirin’s mechanism leads to higher bleeding risks.",
          "Potential benefits must outweigh risks in bleeding disorders."
        ],
        "caveats": [
          "Further evidence is needed to assess safety fully."
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_warfarin",
          "name": "Warfarin"
        },
        "score": 0.32,
        "graph_snapshot_ref": "GE_H2_round5",
        "key_assumptions": [
          "Warfarin significantly affects coagulation factors.",
          "Long-term bleeding risk management remains uncertain."
        ],
        "caveats": [
          "Additional data required on its impact for bleeding disorders."
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_clopidogrel",
          "name": "Clopidogrel"
        },
        "score": 0.31,
        "graph_snapshot_ref": "GE_H3_round5",
        "key_assumptions": [
          "Clopidogrel's action on platelets introduces risks for bleeding disorders.",
          "Need to weigh benefits against potential adverse effects."
        ],
        "caveats": [
          "Uncertainty about its hemocompatibility in vascular conditions."
        ],
        "confidence": "low"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Target(COX)/(Factors)→Pathway(Hemostasis/Anticoagulation)→Phenotype(Bleeding Disorders)",
          "reason": "Highlighting mechanisms links drugs to bleeding risk consideration."
        }
      ],
      "remaining_gaps": [
        "Need definitive risk assessment methods for all candidates in bleeding disorders.",
        "Lack of evidence showing safe usage parameters for all evaluated drugs."
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B"
          ],
          "impact_summary": "Established connections between drugs and bleeding pathways."
        },
        {
          "round": 2,
          "seeds": [
            "C",
            "D"
          ],
          "impact_summary": "Clarified conflicts around drug safety; need for further investigation."
        }
      ],
      "lessons": [
        "Aspirin's and Warfarin's risks emphasize the need for quantifiable data.",
        "Continuing to evaluate dosing strategies and concurrent conditions is essential."
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "Encourage exploration of safety profiles associated with long-term use of each drug."
      },
      {
        "role": "Skeptic",
        "patch": "Highlight potential complications and necessary monitoring in bleeding disorders."
      }
    ],
    "heuristics": [
      {
        "when": "出血性疾病患者",
        "then": "优先评估抗凝药物的长期安全性和必要性。"
      },
      {
        "when": "血栓化病史",
        "then": "重视减轻出血风险的综合管理策略。"
      }
    ]
  }
}